GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:ROG) » Definitions » Cash Flow from Operations

Roche Holding AG (XSWX:ROG) Cash Flow from Operations

: CHF16,095 Mil (TTM As of Dec. 2023)
View and export this data going back to 2001. Start your Free Trial

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2023, Roche Holding AG's Net Income From Continuing Operations was CHF4,795 Mil. Its Depreciation, Depletion and Amortization was CHF1,714 Mil. Its Change In Working Capital was CHF697 Mil. Its cash flow from deferred tax was CHF110 Mil. Its Cash from Discontinued Operating Activities was CHF0 Mil. Its Asset Impairment Charge was CHF0 Mil. Its Stock Based Compensation was CHF447 Mil. And its Cash Flow from Others was CHF434 Mil. In all, Roche Holding AG's Cash Flow from Operations for the six months ended in Dec. 2023 was CHF8,197 Mil.


Roche Holding AG Cash Flow from Operations Historical Data

The historical data trend for Roche Holding AG's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Operations
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22,385.00 18,566.00 20,976.00 17,803.00 16,095.00

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Operations Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,764.00 9,171.00 8,632.00 7,898.00 8,197.00

Roche Holding AG Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Roche Holding AG's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

Roche Holding AG's Cash Flow from Operations for the quarter that ended in Dec. 2023 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF16,095 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG  (XSWX:ROG) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Roche Holding AG's net income from continuing operations for the six months ended in Dec. 2023 was CHF4,795 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Roche Holding AG's depreciation, depletion and amortization for the six months ended in Dec. 2023 was CHF1,714 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Roche Holding AG's change in working capital for the six months ended in Dec. 2023 was CHF697 Mil. It means Roche Holding AG's working capital increased by CHF697 Mil from Jun. 2023 to Dec. 2023 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Roche Holding AG's cash flow from deferred tax for the six months ended in Dec. 2023 was CHF110 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Roche Holding AG's cash from discontinued operating Activities for the six months ended in Dec. 2023 was CHF0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Roche Holding AG's asset impairment charge for the six months ended in Dec. 2023 was CHF0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Roche Holding AG's stock based compensation for the six months ended in Dec. 2023 was CHF447 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Roche Holding AG's cash flow from others for the six months ended in Dec. 2023 was CHF434 Mil.


Roche Holding AG Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (XSWX:ROG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG (XSWX:ROG) Headlines